Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape

This publication has 31 references indexed in Scilit:

• Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
  Immunity, 2013
• Comprehensive genomic characterization of squamous cell lung cancers
  Nature, 2012
• Stromal CD4/CD25 positive T-cells are a strong and independent prognostic factor in non-small cell lung cancer patients, especially with adenocarcinomas
  Lung Cancer, 2012
• Differential Pathogenesis of Lung Adenocarcinoma Subtypes Involving Sequence Mutations, Copy Number, Chromosomal Instability, and Methylation
  PLOS ONE, 2012
• Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer
  Cancer Immunology, Immunotherapy, 2012
• Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types
  Clinical Cancer Research, 2010
• Relapse-Related Molecular Signature in Lung Adenocarcinomas Identifies Patients With Dismal Prognosis
  Journal of Clinical Oncology, 2009
• Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
  Nature Medicine, 2008
• Gene Expression Profiling Reveals Reproducible Human Lung Adenocarcinoma Subtypes in Multiple Independent Patient Cohorts
  Journal of Clinical Oncology, 2006
• Gene Expression Signatures for Predicting Prognosis of Squamous Cell and Adenocarcinomas of the Lung
  Cancer Research, 2006